Tiaan Consumer Ltd. (BSE: TIAANC.BO) AI-Powered Stock Analysis
See how Tiaan Consumer Ltd. scores across key metrics like financial growth, valuation, and market position on the BSE, using AI-driven evaluation.
TIAANC.BO●BSE
HealthcareMedical - Pharmaceuticals
₹6.28
₹0.28(4.67%)
Indian Market opens in 6h 37m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerTiaan Consumer Ltd. (BSE: TIAANC.BO) Stock Overall Grade
Tiaan Consumer Ltd.'s grade for its BSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Tiaan Consumer Ltd.'s overall BSE stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
57/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Tiaan Consumer Ltd. (BSE: TIAANC.BO) AI-Powered Stock Analysis
On the BSE, TIAANC.BO demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (57/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the BSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(BSE: TIAANC.BO) Component Analysis Explained
Understand the key factors behind each Tiaan Consumer Ltd. (BSE: TIAANC.BO) stock grade, including financials, comparisons, and forecasts.